Cargando…

Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus -(HIV) positive pregnant women

BACKGROUND: In many developing countries with a significant proportion of human immunodeficiency virus (HIV)-positive patients are women of child-bearing age and would require antiretroviral therapy. This study aimed at evaluating the effect of highly active antiretroviral therapy (HAART) on some sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evarista, Osime Odaburhine, Ezimokhai, Tijani Paul, Airiagbonbu, Blessing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529161/ https://www.ncbi.nlm.nih.gov/pubmed/33062988 http://dx.doi.org/10.4103/ijstd.IJSTD_107_17

Ejemplares similares

Packed cell volume Platelet count, PT, PTTK and Fibrinogen concentration of HIV positive patients on antiretroviral drugs
por: Osime, Evarista Odaburhine, et al.
Publicado: (2015)

Fibrinolytic changes in pregnant women on highly active antiretroviral therapy
por: Osime, Odaburhine E., et al.
Publicado: (2015)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana
por: Lawler, Kathy, et al.
Publicado: (2011)

Relationship between Neutrophil-to-Lymphocyte Ratio and Inflammatory Markers in Sickle Cell Anaemia Patients with Proteinuria
por: Emokpae, Mathias Abiodun, et al.
Publicado: (2016)

HAART and ATT in the HIV-positive patient with tuberculosis
por: Jhiens, Zi Z., et al.
Publicado: (2012)

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
por: Lima, Viviane D, et al.
Publicado: (2006)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

Human immunodeficiency virus infection (HIV)–associated rheumatic manifestations in thepre- and post-HAART eras
por: Vega, Luis E., et al.
Publicado: (2020)

Factors associated with non-adherence to HAART in HIV-positive pregnant women during pregnancy, peri- and postpartum in Lima, Peru
por: Tejada, Romina, et al.
Publicado: (2010)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

Emergency department utilization by HIV-positive adults in the HAART era
por: Venkat, Arvind, et al.
Publicado: (2008)

Intensive Care Usage by HIV-Positive Patients in the HAART Era
por: Turtle, L., et al.
Publicado: (2011)

Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)
por: Teichmann, J, et al.
Publicado: (2009)

Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects
por: Ghosh, Santosh K., et al.
Publicado: (2013)

Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
por: Hejazi, Nazisa, et al.
Publicado: (2014)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Anemia and Risk Factors in HAART Naïve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study
por: Gedefaw, Lealem, et al.
Publicado: (2013)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
por: Alibhai, Arif, et al.
Publicado: (2010)

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria
por: Taiwo, Olaniyi O, et al.
Publicado: (2010)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients
por: Akinbami, Akinsegun, et al.
Publicado: (2012)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
por: Neeraja, M., et al.
Publicado: (2020)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Premature and accelerated aging: HIV or HAART?
por: Smith, Reuben L., et al.
Publicado: (2013)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
por: Chauhan, Nidhi, et al.
Publicado: (2021)

Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
por: Tilahun, Anemut, et al.
Publicado: (2022)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

A study of neuropsychological profile of human immunodeficiency virus-positive children and adolescents on antiretroviral therapy
por: Murthy, Vasantmeghna S., et al.
Publicado: (2018)

Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)
por: Misra, Ranjita, et al.
Publicado: (2013)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

HIV Positivity Disclosure Among Children Living with HIV/AIDS and Currently on HAART in Dessie, Northeast Ethiopia
por: Chanie, Muluken Genetu, et al.
Publicado: (2022)

Changes in Lipid Indices in HIV+ Cases on HAART
por: Ji, Shujing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nr3s2vab6sbmgu2bnmrtdiloja